Progressive, metastatic Medullary thyroid cancer
Also known as: Progressive metastatic medullary thyroid cancer
Drug | Drug Name | Drug Description |
---|---|---|
DB08875 | Cabozantinib | A tyrosine kinase inhibitor used to treat advanced renal cell carcinoma, hepatocellular carcinoma, and medullary thyroid cancer. |
Drug | Drug Name | Phase | Status | Count |
---|